232 related articles for article (PubMed ID: 19297381)
1. Drug discovery in psychiatric illness: mining for gold.
Elmer GI; Kafkafi N
Schizophr Bull; 2009 Mar; 35(2):287-92. PubMed ID: 19297381
[TBL] [Abstract][Full Text] [Related]
2. Mining mouse behavior for patterns predicting psychiatric drug classification.
Kafkafi N; Mayo CL; Elmer GI
Psychopharmacology (Berl); 2014 Jan; 231(1):231-42. PubMed ID: 23958942
[TBL] [Abstract][Full Text] [Related]
3. A data mining approach to in vivo classification of psychopharmacological drugs.
Kafkafi N; Yekutieli D; Elmer GI
Neuropsychopharmacology; 2009 Feb; 34(3):607-23. PubMed ID: 18719620
[TBL] [Abstract][Full Text] [Related]
4. Removing obstacles in neuroscience drug discovery: the future path for animal models.
Markou A; Chiamulera C; Geyer MA; Tricklebank M; Steckler T
Neuropsychopharmacology; 2009 Jan; 34(1):74-89. PubMed ID: 18830240
[TBL] [Abstract][Full Text] [Related]
5. Increasing pharmacological knowledge about human neurological and psychiatric disorders through functional neuroimaging and its application in drug discovery.
Nathan PJ; Phan KL; Harmer CJ; Mehta MA; Bullmore ET
Curr Opin Pharmacol; 2014 Feb; 14():54-61. PubMed ID: 24565013
[TBL] [Abstract][Full Text] [Related]
6. The genetic and epigenetic landscape for CNS drug discovery targeting cross-diagnostic behavioral domains.
de Mooij-van Malsen AJ; Pjetri E; Kas MJ
Eur J Pharmacol; 2015 Apr; 753():135-9. PubMed ID: 25107283
[TBL] [Abstract][Full Text] [Related]
7. [Animal models of psychiatric disorder and their validity--from the perspective of behavioral pharmacology].
Yamamoto T; Une T
Nihon Yakurigaku Zasshi; 2002 Sep; 120(3):173-80. PubMed ID: 12271512
[TBL] [Abstract][Full Text] [Related]
8. The Evolving Role of Animal Models in the Discovery and Development of Novel Treatments for Psychiatric Disorders.
Teal LB; Ingram SM; Bubser M; McClure E; Jones CK
Adv Neurobiol; 2023; 30():37-99. PubMed ID: 36928846
[TBL] [Abstract][Full Text] [Related]
9. Challenges and opportunities for the development of new antipsychotic drugs.
Forray C; Buller R
Biochem Pharmacol; 2017 Nov; 143():10-24. PubMed ID: 28522405
[TBL] [Abstract][Full Text] [Related]
10. Enhancing the Utility of Preclinical Research in Neuropsychiatry Drug Development.
Kaffman A; White JD; Wei L; Johnson FK; Krystal JH
Methods Mol Biol; 2019; 2011():3-22. PubMed ID: 31273690
[TBL] [Abstract][Full Text] [Related]
11. Failed drug discovery in psychiatry: time for human genome-guided solutions.
Papassotiropoulos A; de Quervain DJ
Trends Cogn Sci; 2015 Apr; 19(4):183-7. PubMed ID: 25727774
[TBL] [Abstract][Full Text] [Related]
12. The use of the zebrafish model in stress research.
Steenbergen PJ; Richardson MK; Champagne DL
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(6):1432-51. PubMed ID: 20971150
[TBL] [Abstract][Full Text] [Related]
13. The Emerging Role of Neuronal Organoid Models in Drug Discovery: Potential Applications and Hurdles to Implementation.
Struzyna LA; Watt ML
Mol Pharmacol; 2021 Apr; 99(4):256-265. PubMed ID: 33547249
[TBL] [Abstract][Full Text] [Related]
14. Screening drugs for myocardial disease in vivo with zebrafish: an expert update.
Zhao Y; Zhang K; Sips P; MacRae CA
Expert Opin Drug Discov; 2019 Apr; 14(4):343-353. PubMed ID: 30836799
[TBL] [Abstract][Full Text] [Related]
15. Of mice and men: bridging the translational disconnect in CNS drug discovery.
Geerts H
CNS Drugs; 2009 Nov; 23(11):915-26. PubMed ID: 19845413
[TBL] [Abstract][Full Text] [Related]
16. The Difficult Path to the Discovery of Novel Treatments in Psychiatric Disorders.
Gribkoff VK; Kaczmarek LK
Adv Neurobiol; 2023; 30():255-285. PubMed ID: 36928854
[TBL] [Abstract][Full Text] [Related]
17. Back to the future of psychopharmacology: A perspective on animal models in drug discovery.
Hendriksen H; Groenink L
Eur J Pharmacol; 2015 Jul; 759():30-41. PubMed ID: 25814259
[TBL] [Abstract][Full Text] [Related]
18. CNS Target Identification and Validation: Avoiding the Valley of Death or Naive Optimism?
Hutson PH; Clark JA; Cross AJ
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():171-187. PubMed ID: 27575715
[TBL] [Abstract][Full Text] [Related]
19. New approaches in psychiatric drug development.
van der Doef TF; Zaragoza Domingo S; Jacobs GE; Drevets WC; Marston HM; Nathan PJ; Tome MB; Tamminga CA; van Gerven JMA; Kas MJH
Eur Neuropsychopharmacol; 2018 Sep; 28(9):983-993. PubMed ID: 30056086
[TBL] [Abstract][Full Text] [Related]
20. Preclinical epigenetic models for screening epigenetic drugs for schizophrenia.
Peedicayil J
J Pharmacol Toxicol Methods; 2016; 77():1-5. PubMed ID: 26370661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
